Immunohistochemistry Market: Antibodies Segment Dominated And Accounted For The Largest Share

 Immunohistochemistry Industry Overview

The global immunohistochemistry market size was valued at USD 1.89 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030. Increasing implementation of automation and machine learning in IHC, coupled with the introduction of technologically advanced Immunohistochemistry (IHC)  solutions, is expected to significantly drive the market over the forecast period. Advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis. In addition, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further propelling the market growth.

For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Companies continue to launch novel products to strengthen their market position, which leads to revenue generation. For instance, in March 2021, Roche launched the DISCOVERY Green HRP kit to detect and profile biomarkers and cell populations in tissue-based research. This kit can be utilized in combination with other detection kits, expanding the multiplexing capacity of in situ hybridization andIHC. The immunohistochemistry technology is limited to single parametric evaluations of a sample.

Newer techniques, such as multiplexed IHC, however, allow multiparametric and detailed analysis from a single tissue segment by utilizing advanced methods of mass spectrometric detection. Multiplexed IHC helps address the technical challenges posed by the labeled fluorescence detection-based method, thereby spurring the market revenue. The growing elderly population in both developed and emerging nations would favorably impact the market. The frequency of age-related disorders is expected to rise dramatically as the global geriatric population grows significantly. RT-PCR, IHC, and an electron microscope were used to detect the virus, indicating that the effect of SARS-CoV-2 is not limited to the lungs.


Gather more insights about the market drivers, restrains and growth of the
Global Immunohistochemistry market

Browse through Grand View Research's Biotechnology Industry Research Reports.

  • Cell Dissociation Market - Cell dissociation is a laboratory process used to separate cells from tissue or other cells. This process, also known as trypsinization, utilizes a proteolytic enzyme to break down proteins and separate cells from the cell culture medium.

  • Exosomes Market - The global exosomes market size was valued at USD 112.25 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 32.75% by 2030.

 

Immunohistochemistry Market Segmentation

Grand View Research has segmented the global immunohistochemistry market based on product, application, end-use, and region:

IHC Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Antibodies
  • Equipment
  • Reagents
  • Kits

IHC Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Diagnostics
  • Drug Testing
  • Forensic applications

IHC End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

IHC Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • January 2021: Biocare medical LLC launched the ONCORE Pro, a fully automated in vitro diagnostic benchtop system for In-situ Hybridization (ISH) and IHC applications.

  • January 2021: Abcam and Shuwen Biotech (Shuwen) entered into a strategic alliance for developing and commercializing Companion Diagnostics (CDx).

 

Key Companies profiled:

Some prominent players in the global immunohistochemistry market include:

  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Danaher Corporation
  • Perkinelmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Bio SB
  • Agilent Technologies, Inc.
  • Abcam plc.

 

Order a free sample PDF of the Immunohistochemistry Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Popular posts from this blog

Global Composable Infrastructure Market Analysis Based On Component, End-Use, And Region

Insights into the Future: Analyzing the Endoscopy Devices Industry from 2023 to 2030

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report